Biotech & Clinical Trials: Molecular Partners and Orano Med dosed the first patients in a US Phase 1/2a trial of DLL3-targeting Radio-DARPin MP0712, with early data expected soon and fuller results in 2027. Gene Therapy: Vertex won FDA approval for expanded CASGEVY use for children ages 2+ with sickle cell disease or transfusion-dependent beta thalassemia, extending access to a genetic therapy already reshaping treatment timelines. Public Health & Safety: Boston and the Northeast braced for a heat dome ahead of July 4, with utilities in Massachusetts preparing for demand spikes and residents urged to reduce strain on the grid. Energy & Infrastructure: Eversource described ways to reroute power and use customer thermostat participation to prevent outages during extreme heat. STEM & Workforce: UMass Amherst’s ARROW-SEA 2026 trained the next offshore wind workforce through a multi-university accelerator, while a new “Blue Envelope” autism-support law traces back to UMass research and aims to improve police interactions. Policy & Environment: A Massachusetts “Dark Skies” bill advanced to cut light pollution and lower streetlight operating costs. Housing (Local Policy): A new Greater Boston housing discussion argues for bringing back triple-deckers as one way to stabilize costs. Tech & Compliance: Alibaba and its US payment processor agreed to pay $600M to resolve a US drug sales probe tied to compliance failures on its platforms.